Syntone Ventures LLC, 10% Owner at Outlook Therapeutics, Inc. (OTLK), bought 1,646,090 shares at $1.22 ($2.0M) on 2020-07-15, disclosed to the SEC on 2020-07-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.22 | 823,045 | $1.0M | 50.0% |
| 2 | $1.22 | 823,045 | $1.0M | 50.0% |
| Total | $1.22 avg | 1,646,090 | $2.0M | 100% |